Highlights and Quick Summary
- Shareholders Equity (Tangible) for the quarter ending February 28, 2022 was $358 Million (a -3.49% decrease compared to previous quarter)
- Year-over-year quarterly Shareholders Equity (Tangible) decreased by -7.28%
- Annual Shareholders Equity (Tangible) for 2021 was $365 Million (a 64.78% increase from previous year)
- Annual Shareholders Equity (Tangible) for 2020 was $222 Million (a -9.79% decrease from previous year)
- Annual Shareholders Equity (Tangible) for 2019 was $246 Million (a 69.85% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Shareholders Equity (Tangible) of Organigram Holdings Inc.
Most recent Shareholders Equity (Tangible)of OGI including historical data for past 10 years.Interactive Chart of Shareholders Equity (Tangible) of Organigram Holdings Inc.
Organigram Holdings Inc. Shareholders Equity (Tangible) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $358.07 | – | – | – | – |
| 2021 | $371.0 | $364.98 | $386.19 | $208.32 | $364.98 |
| 2020 | $240.68 | $221.5 | $226.79 | $284.53 | $221.5 |
| 2019 | $246.35 | $245.53 | $249.8 | $206.65 | $245.53 |
| 2018 | $178.08 | $144.56 | – | – | $144.56 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic